Andrew L. Feldman

Also affiliated with Mayo Clinic in Arizona

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.1Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Papers

Driven by 26 papers — median percentile 45. Top paper: “The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes”.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

1.1DataRank · unranked

1538 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

Haematologica(2021)10.3324/haematol.2020.271957

N/A

0.663DataRank · unranked

82 citations

Blanca González‐Farré, Alina Nicolae, Svetlana Pack, Guillem Clot, Ferran Nadeu +21 more

Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

Blood Cancer Journal(2021)10.1038/s41408-021-00521-4

N/A

0.631DataRank · unranked

66 citations

Angelo Famà, Melissa C. Larson, Andrew L. Feldman, José C. Villasboas, Zhi-Zhang Yang +20 more

Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102592

N/A

0.607DataRank · unranked

14 citations

Côme Bommier, Juan Pablo Alderuccio, Michele Merli, Nicole Fabbri, Maria Elena Nizzoli +30 more

Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0573

N/A

0.510DataRank · unranked

29 citations

Alyssa Bouska, Sunandini Sharma, Catalina Amador, Saumyaranjan Mallick, Tyler A. Herek +21 more

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

Blood Cancer Journal(2024)10.1038/s41408-024-01080-0

N/A

0.385DataRank · unranked

12 citations

Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper +25 more

Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma

Journal of Hematopathology(2020)10.1007/s12308-020-00418-4

N/A

0.373DataRank · unranked

11 citations

Alanna Maguire, Ryan S. Robetorye, Andrew L. Feldman, Sergei Syrbu, Allison Rosenthal +2 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0.373DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma

Hematological Oncology(2022)10.1002/hon.3098

N/A

0.312DataRank · unranked

7 citations

Raphael Mwangi, Alexandra N. Smith, Matthew J. Maurer, Umar Farooq, Rebecca L. King +9 more

RNAseq identification of FISH‐cryptic BCL6::TP63 rearrangement in ALK‐negative anaplastic large‐cell lymphoma

Histopathology(2022)10.1111/his.14674

N/A

0.292DataRank · unranked

6 citations

Rhett P. Ketterling, Grzegorz S. Nowakowski, Surendra Dasari, Andrew L. Feldman, Nada Ahmed

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood(2024)10.1182/blood.2024025681

N/A

0.269DataRank · unranked

5 citations

Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen +18 more

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab

British Journal of Haematology(2023)10.1111/bjh.19153

N/A

0.269DataRank · unranked

5 citations

Allison Rosenthal, Ryan S. Robetorye, Raphael Mwangi, Matthew J. Maurer, Diego Villa +20 more

Vaccination History and Risk of Lymphoma and Its Major Subtypes

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0383

N/A

0.241DataRank · unranked

4 citations

Melissa C. Larson, Stephen M. Ansell, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call +10 more

Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation

Human Pathology(2023)10.1016/j.humpath.2023.08.007

N/A

0.165DataRank · unranked

2 citations

Naoki Oishi, Min Shi, Surendra Dasari, Stephen M. Ansell, Rhett P. Ketterling +2 more

29 | A COMPARATIVE ANALYSIS OF HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA AT DIAGNOSIS (COMPOSITE LYMPHOMA) AND SEQUENTIALLY TRANSFORMED FOLLICULAR LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_29

N/A

0DataRank · unranked

0 citations

Melissa C. Larson, Jonathan Day, Urshila Durani, Mazie Tsang, Dai Chihara +22 more

CA9 expression in breast implant‐associated anaplastic large cell lymphoma presenting in a lymph node

Histopathology(2022)10.1111/his.14666

N/A

0DataRank · unranked

7 citations

Andrew L. Feldman, Naoki Oishi

Primary cutaneous gamma/delta T‐cell lymphoma with simultaneous JAK2 and TP63 rearrangements: a new double‐hit?

Histopathology(2023)10.1111/his.14973

N/A

0DataRank · unranked

2 citations

N. Nora Bennani, Nneka I. Comfere, Urshila Durani, Patricia T. Greipp, Andrew L. Feldman +1 more

Data from Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma

(2023)10.1158/1078-0432.c.6530648.v1

Top 100%

0DataRank

Top 100%0 citations

Alyssa Bouska, Sunandini Sharma, Catalina Amador, Saumyaranjan Mallick, Tyler A. Herek +21 more

Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning

Diagnostic Pathology(2024)10.1186/s13000-023-01425-6

N/A

0DataRank · unranked

6 citations

Muhammad Khalid Khan Niazi, Andrew L. Feldman, David L. Jaye, Christopher R. Flowers, Lee Cooper +2 more

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

UNC Libraries(2024)10.17615/vsck-8v23

N/A

0DataRank · unranked

0 citations

N. Chatterjee, A. Maria, Lynn R. Goldin, Vijai Joseph, Sílvia de Sanjosé +76 more

Risk of lymphoid malignancy associated with cancer predisposition genes

Blood Cancer Journal(2025)10.1038/s41408-025-01283-z

N/A

0DataRank · unranked

8 citations

Raphael Mwangi, Dennis P. Robinson, Cristine Allmer, Allison Rosenthal, Thomas M. Habermann +95 more

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma

American Journal of Hematology(2025)10.1002/ajh.27736

N/A

0DataRank · unranked

6 citations

Weiwei Zhang, Sunandini Sharma, Harald Holte, Roshani Shah, Waseem Lone +39 more

Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-24-1610

N/A

0DataRank · unranked

0 citations

Dennis P. Robinson, Lisa M. Rimsza, Melissa C. Larson, Rebecca L. King, Grzegorz S. Nowakowski +9 more

271 | LEUKEMIC NON‐NODAL MANTLE CELL LYMPHOMA IS NOT NECESSARILY EQUIVALENT TO INDOLENT MCL: A REPORT FROM THE LEO COHORT STUDY

Hematological Oncology(2025)10.1002/hon.70094_271

N/A

0DataRank · unranked

0 citations

Yihua Chen, Jeffrey M. Switchenko, Suheil Albert Atallah‐Yunes, Georgio Pongas, Mary P. Watkins +16 more

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma

Haematologica(2020)10.3324/haematol.2019.245860

N/A

0DataRank · unranked

48 citations

Tanya Hundal, Jessica L. Phillips, Surendra Dasari, Guangzhen Hu, David S. Viswanatha +16 more

Andrew L. Feldman

Indexed papers

Top data-sharing exemplar

Papers